Capital International LTD Incyte Corp Transaction History

Capital International LTD

$2.23 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $183,450 - $229,687	2,772 Added 10.77%	28,522 $1.9 Million
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $2.46 Million - $2.97 Million	-37,250 Reduced 59.13%	25,750 $2.05 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $76,198 - $89,154	1,203 Added 1.95%	63,000 $4.62 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $49,648 - $60,746	-723 Reduced 1.16%	61,797 $4.25 Million
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $647,346 - $709,430	-8,105 Reduced 11.48%	62,520 $5.26 Million
Q1 2021 May 14, 2021	SELL	$76.02 - $100.5 $437,875 - $578,880	-5,760 Reduced 7.54%	70,625 $5.74 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $172,622 - $208,882	2,138 Added 2.88%	76,385 $6.64 Million
Q3 2020 Nov 13, 2020	SELL	$85.07 - $109.69 $174,988 - $225,632	-2,057 Reduced 2.7%	74,247 $6.66 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $346,568 - $508,920	-4,672 Reduced 5.77%	76,304 $7.93 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $338,013 - $459,939	-5,350 Reduced 6.2%	80,976 $5.93 Million
Q4 2019 Feb 18, 2020	BUY	$73.04 - $95.72 $1.93 Million - $2.54 Million	26,484 Added 44.26%	86,326 $7.54 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $2.09 Million - $2.48 Million	28,718 Added 92.27%	59,842 $4.44 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $113,514 - $136,952	-1,544 Reduced 4.73%	31,124 $2.64 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $53,136 - $73,710	836 Added 2.63%	32,668 $2.81 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $27,787 - $33,221	475 Added 1.51%	31,832 $2.02 Million
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $4.26 Million - $5.12 Million	-68,954 Reduced 68.74%	31,357 $2.17 Million
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $52,817 - $72,894	-868 Reduced 0.86%	100,311 $6.72 Million
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $466,049 - $566,598	-5,611 Reduced 5.25%	101,179 $8.43 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $34.3 Million - $42.7 Million	-366,226 Reduced 77.42%	106,790 $10.1 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $51.6 Million - $65.4 Million	473,016	473,016 $55.2 Million

Others Institutions Holding INCY

# of Institutions

644

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

News

Stay updated on Capital International LTD with notifications on news.

Account